Thrombectomy Devices Market is expected to rise at a CAGR of 6.83% by 2032, estimates DelveInsight

The thrombectomy devices market was valued at USD 1,656.88 million in 2024 and is projected to reach USD 2,806.85 million by 2032, advancing at a CAGR of 6.83% during 2025-2032. Market growth is being propelled by several key drivers, including the rising global burden of neurological and cardiovascular disorders such as acute ischemic stroke, pulmonary embolism, and deep vein thrombosis, which require timely and effective interventions.

A growing preference for minimally invasive treatment options, favored for their shorter recovery times and reduced risks, is further boosting demand. Moreover, continuous technological advancements and product launches by leading players, focused on next-generation thrombectomy devices that improve procedural efficiency and patient outcomes-are significantly shaping market dynamics. Together, these factors are fostering a favorable outlook for the thrombectomy devices market, supporting steady expansion throughout the forecast period.

DelveInsight's Thrombectomy Devices Market Insights report provides the current and forecast market analysis, individual leading Thrombectomy Devices companies' market shares, challenges, Thrombectomy Devices market drivers, barriers, and trends, and key Thrombectomy Devices companies in the market.

Request for a sample page report @ https://www.delveinsight.com/report-store/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Thrombectomy Devices Market Report
The Thrombectomy Devices market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Thrombectomy Devices market during the forecast period.
Notable Thrombectomy Devices companies such as Stryker, Abbott Laboratories, Boston Scientific Corporation, Argon Medical Devices, Contego Medical, Inc., Mermaid Medical, Surmodics, Inc., Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., Edwards Lifesciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroPort Scientific Corporation, Thrombolex, phenox GmbH, Acandis GmbH, Innova Vascular, Vesalio Inc., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., and several others are currently operating in the Thrombectomy Devices market.
In February 2025, Stryker finalized the acquisition of Inari Medical, Inc., bolstering its presence in the thrombectomy market. Inari's portfolio-featuring the FlowTriever® System for pulmonary embolism and the ClotTriever® System for peripheral vessel thrombectomy-adds strong synergies to Stryker's established Neurovascular business.
Also in February 2025, Shanghai Tendfo Medical Device Co., Ltd. secured NMPA approval in China for the TendviaTM Pulmonary Artery Thrombectomy System. Designed for patients with acute high-risk or intermediate-risk pulmonary embolism, the system provides a minimally invasive transcatheter option for clot removal.
In September 2024, Argon Medical Devices introduced the CLEANER VacTM Thrombectomy System, a disposable, large-bore aspiration device engineered to rapidly and effectively clear thrombus from the peripheral venous vasculature, improving blood flow in compromised vessels.
Earlier, in January 2023, phenox Inc. announced FDA 510(k) clearance for its pRESET® Thrombectomy Device, indicated for the treatment of acute ischemic stroke. The mechanical device is specifically designed to restore cerebral blood flow in patients experiencing stroke-related arterial blockages.

To read more about the latest highlights related to the Thrombectomy Devices market, get a snapshot of the key highlights entailed in the Global Thrombectomy Devices Market Report https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Thrombectomy Devices Overview

Thrombectomy devices are medical instruments designed to remove blood clots from blood vessels, restoring normal circulation and reducing the risk of severe complications such as stroke, pulmonary embolism, and peripheral artery disease. These devices are widely used in neurovascular, cardiovascular, and peripheral vascular interventions, playing a critical role in managing life-threatening thromboembolic conditions.

The market for thrombectomy devices is experiencing strong growth, driven by the rising global prevalence of stroke, coronary heart disease, pulmonary embolism, and deep vein thrombosis (DVT). Additionally, the increasing geriatric population, which is more prone to vascular disorders, and the growing demand for minimally invasive treatment approaches are fueling adoption.

Continuous technological advancements and frequent product launches by leading players are further boosting market expansion. Modern thrombectomy systems are designed to improve procedural efficiency, patient safety, and clinical outcomes, while reducing hospital stays and overall treatment costs.

Regionally, North America dominates the market, supported by advanced healthcare infrastructure, strong presence of key medical device companies, and favorable reimbursement policies. However, Asia-Pacific and Europe are also emerging as significant growth regions due to increasing disease burden, growing awareness, and expanding access to advanced treatment options.

Overall, thrombectomy devices are expected to play an increasingly vital role in vascular intervention strategies, with the global market projected to witness sustained growth over the coming years.

Thrombectomy Devices Market Insights

North America is projected to dominate the thrombectomy devices market in 2024, supported by multiple factors. This leadership stems from the high prevalence of neurovascular, peripheral, and coronary vascular diseases, a rapidly aging population, and the continuous stream of technological innovations and product launches from leading regional device manufacturers. Alongside these drivers, advanced healthcare infrastructure, favorable reimbursement frameworks, and rising awareness of minimally invasive procedures are expected to further strengthen North America's market position over the forecast period.

Data from the Centers for Disease Control and Prevention (CDC, 2024) revealed that more than 795,000 people in the U.S. suffer a stroke each year, with nearly 185,000 cases (about 1 in 4) occurring in individuals with a prior history of stroke. The CDC also noted that around 900,000 Americans are affected by venous thromboembolism (VTE) annually, underscoring the significant clinical demand for effective clot-removal solutions like thrombectomy devices.

The growing burden of coronary heart disease (CHD) and peripheral artery disease (PAD) is another critical factor fueling market growth. According to CDC data (June 2024), approximately 20.5 million Americans were living with CHD as of 2022, while an estimated 6.5 million adults aged 40 and older had PAD. These figures highlight the escalating need for thrombectomy devices, which play a vital role in removing blood clots, restoring circulation, and preventing severe complications across multiple vascular conditions.

To know more about why North America is leading the market growth in the Thrombectomy Devices market, get a snapshot of the Thrombectomy Devices Market Outlook https://www.delveinsight.com/report-store/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Thrombectomy Devices Market Dynamics

According to the British Heart Foundation (2024), an estimated 56 million women and 45 million men worldwide were stroke survivors, underscoring the massive global burden of cerebrovascular disease. The same source highlighted that, as of 2022, nearly 250 million people globally were living with coronary heart disease, further demonstrating the urgent need for effective interventional therapies. Similarly, data from the World Stroke Organization (2023) revealed that 1 in 4 adults over 25 is expected to suffer a stroke in their lifetime, with more than 110 million people worldwide already affected. In such cases, thrombectomy devices are essential in restoring blood flow by physically removing clots that block arteries or veins, particularly in acute, life-threatening conditions like ischemic stroke and peripheral arterial thrombosis.

In Australia, data from the National Institute of Health (2022) reported that more than 17,000 individuals develop venous thromboembolism (VTE) annually, emphasizing the growing need for advanced treatment solutions such as thrombectomy devices.

Further, the British Heart Foundation (2025) noted that over 7.6 million people in the UK were living with heart and circulatory diseases in 2024-including 4 million men and 3.6 million women-with projections showing this figure could rise by 1 million by 2030 and by 2 million by 2040. This highlights the increasing reliance on innovative medical technologies like thrombectomy devices to address these conditions by rapidly removing clots and restoring circulation.

In addition, the American Heart Association (2023) reported that more than 12 million Americans and nearly 200 million people worldwide were living with peripheral artery disease (PAD). This surge in PAD prevalence is further accelerating demand for thrombectomy devices, which are widely used to clear arterial blockages outside the heart and brain, improving blood flow, relieving symptoms, and enhancing long-term patient outcomes.

Thrombectomy Devices Market Drivers:
Growing prevalence of neurological and cardiovascular diseases
Increasing product development activities among the key market players

Get a sneak peek at the Thrombectomy Devices market dynamics @ https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Scope of the Thrombectomy Devices Market Report:
Coverage: Global
Study Period: 2022 to 2032
Key Thrombectomy Devices Companies: Stryker, Abbott Laboratories, Boston Scientific Corporation, Argon Medical Devices, Contego Medical, Inc., Mermaid Medical, Surmodics, Inc., Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., Edwards Lifesciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroPort Scientific Corporation, Thrombolex, phenox GmbH, Acandis GmbH, Innova Vascular, Vesalio Inc., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., and others.

Which MedTech key players in the Thrombectomy Devices market are set to emerge as the trendsetter, explore @ Thrombectomy Devices Companies https://www.delveinsight.com/report-store/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Leber's Hereditary Optic Neuropathy Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

Contact Info:

Kritika Rehani
Assistant Manager, Digital Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.